Prellis Biologics

Prellis Biologics company information, Employees & Contact Information

Updated June 2026

Quick answer

Prellis Biologics is a Biotechnology Research company and founded in 2016. It has approximately 50 employees on record. Contact data was last refreshed in June 2026. Find Prellis Biologics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Prellis Bio is hiring Immunologists! We are expanding our Externalized Immune System, EXIS™, platform with applications in antibody discovery, immunogenicity, and vaccine screening all in the same platform. Prellis Biologics, Inc. is a privately held company based in the San Francisco Bay Area, CA. Apply at www.prellisbio.com.

Company Details

Employees
50
Founded
2016
Address
999 Anthony St., Berkeley,california 94710,united States
Phone
(510) 200-7698
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Berkeley, California
Looking for a particular Prellis Biologics employee's phone or email?

Prellis Biologics Questions

News

Prellis Biologics Enters Multi-Target Drug Discovery & Development Collaboration with Lilly to Advance Human Antibody Therapeutics - Yahoo Finance

Prellis Biologics Enters Multi-Target Drug Discovery & Development Collaboration with Lilly to Advance Human Antibody Therapeutics Yahoo Finance

Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb - Business Wire

Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb Business Wire

Prellis Biologics launches TissueWorkshop™ to accelerate human tissue engineering research - EurekAlert!

Prellis Biologics launches TissueWorkshop™ to accelerate human tissue engineering research EurekAlert!

3Scan Hosts San Francisco Biotech Showcase with Prellis - GlobeNewswire

3Scan Hosts San Francisco Biotech Showcase with Prellis GlobeNewswire

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development - Business Wire

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development Business Wire

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing - GlobeNewswire

Blueberries Announces Strategic Investor & Closing of $1.0 Million Financing GlobeNewswire

Top Prellis Biologics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant